Promethean pushes for CBD registration despite missing clinical trial efficacy target by Steve Jones September 24, 2026September 24, 2026 Sydney-based Promethean BioPharma has opened a $3.2 million capital raise as it revealed plans to fast […]
Promethean BioPharma joins over-the-counter CBD race by Martin Lane November 30, 2023December 1, 2023
